Calcium-based phosphate binder

DRUG2 trials

Sponsors

Genzyme, a Sanofi Company, Chugai Pharma Taiwan

Conditions

Cardiovascular EventsChronic Kidney DiseaseHemodialysisHyperphosphatemia

Phase 4

Dialysis Clinical Outcomes Revisited (DCOR) Trial

CompletedNCT00324571

Genzyme, a Sanofi CompanyChronic Kidney Disease

Start: 2001-03-31End: 2006-02-28Target: 2000Updated: 2015-03-18

Long Term Evaluation of Sevelamer HCl vs. Calcium-based Phosphate Binder in the Treatment of Hyperphosphatemia in Hemodialysis Patients

CompletedNCT01755078

Chugai Pharma TaiwanCardiovascular Events, Hemodialysis, Hyperphosphatemia

Start: 2007-06-30End: 2009-06-30Updated: 2014-08-05